Eterna Therapeutics
ERNA
#10942
Rank
โ‚ฌ3.31 M
Marketcap
2,85ย โ‚ฌ
Share price
-5.48%
Change (1 day)
111.34%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): -1.501ย โ‚ฌ

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -1.420ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2.729ย โ‚ฌ an increase over its 2021 EPS that were of -18.032ย โ‚ฌ.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1.501ย โ‚ฌ
2022-2.729ย โ‚ฌ-84.86%
2021-18.032ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
2,22ย โ‚ฌ-100.16%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-1,85ย โ‚ฌ-99.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
0,95ย โ‚ฌ-100.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-0,09543ย โ‚ฌ-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
1,19ย โ‚ฌ-100.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
0,62ย โ‚ฌ-100.04%๐Ÿ‡บ๐Ÿ‡ธ USA